4//SEC Filing
PYXIS INNOVATIONS INC 4
Accession 0000950138-07-001017
CIK 0001037649other
Filed
Dec 18, 7:00 PM ET
Accepted
Dec 19, 5:24 PM ET
Size
13.0 KB
Accession
0000950138-07-001017
Insider Transaction Report
Form 4
Alticor Global Holdings Inc.
10% Owner
Transactions
- Conversion
Common Stock
2007-12-17$0.64/sh+3,190,988$2,039,680→ 5,941,025 total - Conversion
Convertible Promissory Notes
2007-12-17Exercise: $0.64→ Common Stock (3,190,988 underlying)
PYXIS INNOVATIONS INC
10% Owner
Transactions
- Conversion
Convertible Promissory Notes
2007-12-17Exercise: $0.64→ Common Stock (3,190,988 underlying) - Conversion
Common Stock
2007-12-17$0.64/sh+3,190,988$2,039,680→ 5,941,025 total
SOLSTICE HOLDINGS INC
10% Owner
Transactions
- Conversion
Convertible Promissory Notes
2007-12-17Exercise: $0.64→ Common Stock (3,190,988 underlying) - Conversion
Common Stock
2007-12-17$0.64/sh+3,190,988$2,039,680→ 5,941,025 total
ALTICOR INC
10% Owner
Transactions
- Conversion
Convertible Promissory Notes
2007-12-17Exercise: $0.64→ Common Stock (3,190,988 underlying) - Conversion
Common Stock
2007-12-17$0.64/sh+3,190,988$2,039,680→ 5,941,025 total
Footnotes (2)
- [F1]Pyxis held convertible promissory notes issued by the Issuer with an aggregate original principal amount of $2,000,000 which it elected to convert on December 17, 2007. The original principal amount of the convertible promissory notes, plus accrued interest thereon, was convertible into common stock at any time at a conversion price equal to two times the conversion price of the Issuer's Series A Preferred Stock in effect at the time of the conversion and the note was convertible at any time at the option of Pyxis.
- [F2]Pyxis holds a convertible promissory note issued by the Issuer with an original principal amount of $595,336. The original principal amount of the convertible promissory note, plus accrued interest thereon, is convertible into the Issuer's common stock at any time at the option of Pyxis. This promissory note will be convertible into shares of common stock at a conversion price equal to two times the conversion price of the Issuer's Series A Preferred Stock in effect at the time of conversion. As of September 30, 2007, the convertible promissory note would have been convertible into 861,842 shares of the Issuer's common stock.
Documents
Issuer
INTERLEUKIN GENETICS INC
CIK 0001037649
Entity typeother
Related Parties
1- filerCIK 0001221575
Filing Metadata
- Form type
- 4
- Filed
- Dec 18, 7:00 PM ET
- Accepted
- Dec 19, 5:24 PM ET
- Size
- 13.0 KB